Atai Life Sciences EBITDA Margin 2020-2025 | ATAI

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Atai Life Sciences (ATAI) over the last 10 years. The current EBITDA margin for Atai Life Sciences as of March 31, 2025 is .
Atai Life Sciences EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.00B $-0.10B -4950.00%
2024-09-30 $0.00B $-0.11B 0.00%
2024-06-30 $0.00B $-0.11B 0.00%
2023-12-31 $0.00B $-0.13B 0.00%
2023-09-30 $0.00B $-0.13B 0.00%
2023-06-30 $0.00B $-0.14B 0.00%
2023-03-31 $0.00B $-0.14B 0.00%
2022-09-30 $0.00B $-0.15B 0.00%
2022-06-30 $0.00B $-0.15B 0.00%
2021-12-31 $0.02B $-0.14B -675.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.527B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.257B 18.98
Encompass Health (EHC) United States $11.907B 25.24
DaVita (DVA) United States $10.857B 15.27
Elanco Animal Health (ELAN) United States $7.326B 15.69
Chemed (CHE) United States $6.816B 21.42
Option Care Health (OPCH) United States $5.052B 22.52
RadNet (RDNT) United States $4.151B 263.43
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.062B 22.64
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.372B 33.99
U.S Physical Therapy (USPH) United States $1.166B 30.10
Pennant (PNTG) United States $0.891B 32.71
Aveanna Healthcare Holdings (AVAH) United States $0.835B 47.56
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00